Virtu Financial’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,263
Closed -$28K 2240
2023
Q1
$28K Sell
12,263
-5,579
-31% -$14.1K ﹤0.01% 1181
2022
Q4
$25K Buy
+17,842
New +$30K ﹤0.01% 1225
2022
Q3
Sell
-12,760
Closed -$20K 2374
2022
Q2
$20K Buy
+12,760
New +$48.2K ﹤0.01% 1333
2022
Q1
Sell
-16,566
Closed -$93K 2211
2021
Q4
$93K Buy
+16,566
New +$171K 0.01% 1163

Other funds holding VAXX

Virtu Financial's VAXX Position: Q2 2023 in Review

Virtu Financial sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2023, closing a stake of 12,263 shares — an estimated $28K sold.

Virtu Financial first reported a position in VAXX in Q4 2021 and held it in 4 quarters. The position peaked at $93K in Q4 2021. 49 funds tracked by Wall St. Rank hold VAXX as of Q2 2023.

  • Virtu Financial reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 12,263 Vaxxinity, Inc. Class A Common Stock shares in Q2 2023, an estimated $28K.
  • Virtu Financial first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Virtu Financial's Vaxxinity, Inc. Class A Common Stock position peaked at $93K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.